Wash U Team Finds Genomic Profile May Predict Aromatase Inhibitor Response in Breast Cancer Patients
June 11, 2012
Wash U Team Finds Genomic Profile May Predict Aromatase Inhibitor Response in Breast Cancer Patients
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
December 12, 2012 / Clinical Sequencing News - Sequencing Step Now 'Trivial' Part of Clinical Genomics Pipeline amid Analysis, Reimbursement Challenges
June 13, 2012 / Clinical Sequencing News - WGS IDs Markers of Response to Aromatase Inhibitors; New Trial Will Use Signatures to Guide Treatment
June 13, 2012 / Clinical Sequencing News - Most Viewed Articles on GWDN Last Week
June 11, 2012 / GenomeWeb Daily News - WUSTL, ICR to Use $4M Komen Grant to Develop Breast Cancer Dx, Screen Treatments
June 4, 2012 / GenomeWeb Daily News